Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) traded down 9.1% during trading on Wednesday . The stock traded as low as GBX 1.75 ($0.02) and last traded at GBX 1.75 ($0.02). 200,000 shares changed hands during trading, a decline of 84% from the average session volume of 1,265,205 shares. The stock had previously closed at GBX 1.93 ($0.02).
Advanced Oncotherapy Stock Performance
The firm has a market capitalization of £9.49 million, a price-to-earnings ratio of -25.00 and a beta of 0.06. The company has a debt-to-equity ratio of 98.71, a current ratio of 1.26 and a quick ratio of 0.13. The firm’s fifty day moving average is GBX 1.75 and its 200 day moving average is GBX 1.75.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Featured Articles
- Five stocks we like better than Advanced Oncotherapy
- What is Forex and How Does it Work?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
